AAAAAA
Results:
1-12
|
Results: 12
Authors:
BABE LM
YOAST S
DREYER M
SCHMIDT BF
Citation: Lm. Babe et al., HETEROLOGOUS EXPRESSION OF HUMAN GRANZYME-K IN BACILLUS-SUBTILIS AND CHARACTERIZATION OF ITS HYDROLYTIC ACTIVITY IN-VITRO, Biotechnology and applied biochemistry, 27, 1998, pp. 117-124
Authors:
BABE LM
SCHMIDT B
Citation: Lm. Babe et B. Schmidt, PURIFICATION AND BIOCHEMICAL-ANALYSIS OF WPRA, A 52-KDA SERINE-PROTEASE SECRETED BY BACILLUS-SUBTILIS AS AN ACTIVE COMPLEX WITH ITS 23-KDA PROPEPTIDE, Biochimica et biophysica acta. Protein structure and molecular enzymology, 1386(1), 1998, pp. 211-219
Authors:
BABE LM
UNAL A
CRAIK CS
Citation: Lm. Babe et al., OBSTRUCTION OF HIV-1 PARTICLE RELEASE BY INTERFERON-ALPHA OCCURS BEFORE VIRAL PROTEASE PROCESSING AND IS INDEPENDENT OF ENVELOPE GLYCOPROTEIN, Journal of interferon & cytokine research, 17(5), 1997, pp. 287-293
Authors:
BABE LM
CRAIK CS
Citation: Lm. Babe et Cs. Craik, VIRAL PROTEASES - EVOLUTION OF DIVERSE STRUCTURAL MOTIFS TO OPTIMIZE FUNCTION, Cell, 91(4), 1997, pp. 427-430
Authors:
BABE LM
DREYER M
SCHMIDT B
Citation: Lm. Babe et al., HETEROLOGOUS EXPRESSION OF HUMAN GRANZYME-K AND CHARACTERIZATION OF PEPTIDOLYTIC ACTIVITY IN-VITRO, Molecular biology of the cell, 7, 1996, pp. 184-184
Authors:
CRAIK CS
BABE LM
GOOD A
KUNTZ I
MCPHEE F
ROSE JR
UNAL A
Citation: Cs. Craik et al., ENGINEERING CATALYTICALLY DEFECTIVE HIV PROTEASE HETERODIMERS AS POTENTIAL ANTIVIRALS, The FASEB journal, 10(6), 1996, pp. 2437-2437
Authors:
CRAIK CS
BABE LM
MCPHEE F
ROSE JR
Citation: Cs. Craik et al., ENGINEERING HIV PROTEASE FOR DRUG DESIGN EFFORTS, The FASEB journal, 9(6), 1995, pp. 1254-1254
Authors:
BABE LM
ROSE J
CRAIK CS
Citation: Lm. Babe et al., TRANSDOMINANT INHIBITORY HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 PROTEASEMONOMERS PREVENT PROTEASE ACTIVATION AND VIRION MATURATION, Proceedings of the National Academy of Sciences of the United Statesof America, 92(22), 1995, pp. 10069-10073
Authors:
ROSE JR
BABE LM
CRAIK CS
Citation: Jr. Rose et al., DEFINING THE LEVEL OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 (HIV-1) PROTEASE ACTIVITY REQUIRED FOR HIV-1 PARTICLE MATURATION AND INFECTIVITY, Journal of virology, 69(5), 1995, pp. 2751-2758
Authors:
BABE LM
CRAIK CS
Citation: Lm. Babe et Cs. Craik, CONSTITUTIVE PRODUCTION OF NONENVELOPED HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 PARTICLES BY A MAMMALIAN-CELL LINE AND EFFECTS OF A PROTEASE INHIBITOR ON PARTICLE MATURATION, Antimicrobial agents and chemotherapy, 38(10), 1994, pp. 2430-2439
Authors:
DEVOSS JJ
SUI ZH
DECAMP DL
SALTO R
BABE LM
CRAIK CS
DEMONTELLANO PRO
Citation: Jj. Devoss et al., HALOPERIDOL-BASED IRREVERSIBLE INHIBITORS OF THE HIV-1 AND HIV-2 PROTEASES, Journal of medicinal chemistry, 37(5), 1994, pp. 665-673
Authors:
SALTO R
BABE LM
LI J
ROSE JR
YU ZH
BURLINGAME A
DEVOSS JJ
SUI ZH
DEMONTELLANO PO
CRAIK CS
Citation: R. Salto et al., IN-VITRO CHARACTERIZATION OF NONPEPTIDE IRREVERSIBLE INHIBITORS OF HIV PROTEASES, The Journal of biological chemistry, 269(14), 1994, pp. 10691-10698
Risultati:
1-12
|